Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norepinephrine interruption versus gradual tapering for vasopressor liberation in vasodilatory shock
TCTR20260903001Phase 4Recruiting
- Sponsor
- Faculty of Medicine, Chulalongkorn University
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of norepinephrine in Vasoplegia, sponsored by Faculty of Medicine, Chulalongkorn University. Started May 2026; status: recruiting.
02
Drugs
norepinephrine
03
Conditions
Vasoplegia
Beyond the preview
Go deeper on TCTR20260903001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260903001.